Printed from https://ideas.repec.org/s/spr/eujhec6.html
Content
July 2015, Volume 16, Issue 6
- 573-587 A model-based cost-effectiveness analysis of a grommets-led care pathway for children with cleft palate affected by otitis media with effusion
by Syed Mohiuddin & Katherine Payne & Elisabeth Fenwick & Kevin O’Brien & Iain Bruce - 589-601 Productivity or discrimination? An economic analysis of excess-weight penalty in the Swedish labor market
by Margareta Dackehag & Ulf-G. Gerdtham & Martin Nordin - 603-612 Long-term effects of oral clefts on health care utilization: a sibling comparison
by Morten Pedersen & George Wehby & Dorthe Pedersen & Kaare Christensen - 613-628 Chronic pain patients’ treatment preferences: a discrete-choice experiment
by Axel Mühlbacher & Uwe Junker & Christin Juhnke & Edgar Stemmler & Thomas Kohlmann & Friedhelm Leverkus & Matthias Nübling - 629-645 The effect of neighbourhood mortality shocks on fertility preferences: a spatial econometric approach
by Nkechi Owoo & Samuel Agyei-Mensah & Emily Onuoha - 647-655 Cost-effectiveness of computed tomography coronary angiography versus conventional invasive coronary angiography
by Meryl Darlington & Pascal Gueret & Jean-Pierre Laissy & Antoine Pierucci & Hassani Maoulida & Céline Quelen & Ralph Niarra & Gilles Chatellier & Isabelle Durand-Zaleski - 657-670 Patients’ preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer
by Axel Mühlbacher & Susanne Bethge - 671-681 Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study
by Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle
June 2015, Volume 16, Issue 5
- 455-457 Is personalized medicine a panacea for health management? Some thoughts on its desirability
by Fernando Antoñanzas & Carmelo Juárez-Castelló & Roberto Rodríguez-Ibeas - 459-469 Analysis of the cost and efficiency relationship: experience in the Turkish pay for performance system
by Mehmet Gok & Erkut Altındağ - 471-488 Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
by Oliver Damm & Martin Eichner & Markus Rose & Markus Knuf & Peter Wutzler & Johannes Liese & Hagen Krüger & Wolfgang Greiner - 489-506 Income-related inequity in the use of GP services by children: a comparison of Ireland and Scotland
by Richard Layte & Anne Nolan - 507-515 Economic valuation and determinants of informal care to people with Alzheimer’s disease
by Luz Peña-Longobardo & Juan Oliva-Moreno - 517-527 Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
by Dirk Müller & Lisa Borsi & Claudia Stracke & Stephanie Stock & Björn Stollenwerk - 529-542 Physician–patient relationship and medical accident victim compensation: some insights into the French regulatory system
by Lydie Ancelot & Cornel Oros - 543-559 Health inequalities in the European Union: an empirical analysis of the dynamics of regional differences
by Laia Maynou & Marc Saez & Jordi Bacaria & Guillem Lopez-Casasnovas - 561-567 Consultant duration of clinical practice as a cost determinant of an emergency medical admission
by Seán Cournane & Richard Conway & Donnacha Creagh & Declan Byrne & Bernard Silke
May 2015, Volume 16, Issue 4
- 341-345 Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
by Katelijne Vooren & Alessandro Curto & Livio Garattini - 347-356 Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life
by Jacinto Nogueira & Eva Rodríguez-Míguez - 357-364 Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers
by Jacques Rottembourg & Patrick Tilleul & Gilbert Deray & Antoine Lafuma & Lorraine Zakin & Lamine Mahi & Jorge Wernli - 365-375 The impact of office-based care on hospitalizations for ambulatory care sensitive conditions
by Leonie Sundmacher & Thomas Kopetsch - 377-390 Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
by Jan Jürgensen & Robert Ikenberg & Roger-Axel Greiner & Volker Hösel - 391-405 The Icelandic economic collapse, smoking, and the role of labor-market changes
by Thorhildur Ólafsdóttir & Birgir Hrafnkelsson & Tinna Ásgeirsdóttir - 407-419 Does prospective payment increase hospital (in)efficiency? Evidence from the Swiss hospital sector
by Philippe Widmer - 421-435 Gender differences in French GPs’ activity: the contribution of quantile regressions
by Magali Dumontet & Carine Franc - 437-450 Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?
by Peter Makai & Willemijn Looman & Eddy Adang & René Melis & Elly Stolk & Isabelle Fabbricotti - 451-452 Comment on: “Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care”
by Afschin Gandjour - 453-453 Reply to comment on “Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care”
by Martin Gulliford & Judith Charlton & Nawaraj Bhattarai & Caroline Rudisill
April 2015, Volume 16, Issue 3
- 229-234 Reform of hospital financing in Austria: successes, failures, and the way forward
by Engelbert Theurl - 235-241 SF-6D Portuguese population norms
by Pedro Ferreira & Lara Ferreira & Luis Pereira - 243-254 Examining variations in hospital productivity in the English NHS
by Adriana Castelli & Andrew Street & Rossella Verzulli & Padraic Ward - 255-270 Financial catastrophe and poverty impacts of out-of-pocket health payments in Turkey
by Hacer Özgen Narcı & İsmet Şahin & Hasan Yıldırım - 271-277 On the calculation of the Israeli risk adjustment rates
by Amir Shmueli - 279-288 A duration analysis of the role of cigarette prices on smoking initiation and cessation in developing countries
by Deliana Kostova & Frank Chaloupka & Ce Shang - 289-303 Did the corporatization of Portuguese hospitals significantly change their productivity?
by Diogo Ferreira & Rui Marques - 305-311 Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences
by D. Sittig & H. Friedel & J. Wasem - 313-328 Transforming EQ-5D utilities for use in cost–value analysis of health programs
by Erik Nord & Rune Johansen - 329-340 Equal health, equal work? The role of disability benefits in employment after controlling for health status
by Eva Frutos & Judit Castello
March 2015, Volume 16, Issue 2
- 113-118 Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems
by J.-Matthias Schulenburg & Martin Frank - 119-131 Costs and benefits of home care for the elderly versus residential care: a comparison using propensity scores
by Lucy Kok & Caroline Berden & Klarita Sadiraj - 133-139 Output correlations in probabilistic models with multiple alternatives
by Klemen Naveršnik - 141-151 Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample
by Mengjun Wu & John Brazier & Benjamin Kearns & Clare Relton & Christine Smith & Cindy Cooper - 153-159 Accounting for trends in health poverty: a decomposition analysis for Britain, 1991–2008
by Michal Brzezinski - 161-173 The influence of obesity and overweight on medical costs: a panel data perspective
by Toni Mora & Joan Gil & Antoni Sicras-Mainar - 175-184 The influence of the economic crisis on the association between unemployment and health: an empirical analysis for Spain
by Rosa Urbanos-Garrido & Beatriz Lopez-Valcarcel - 185-199 Price elasticities of alcohol demand: evidence from Russia
by Yevgeniy Goryakin & Bayard Roberts & Martin McKee - 201-218 Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years
by S. Veen & R. Kleef & W. Ven & R. Vliet - 219-223 Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses
by Dirk Müller & Eleanor Pullenayegum & Afschin Gandjour - 225-226 Commentary to: costs of diabetes and its complications in Poland
by Ahmad Fayaz-Bakhsh & Raana Sarvari Mehrabad - 227-227 Reply to commentary on costs of diabetes and its complications in Poland
by Joanna Leśniowska
January 2015, Volume 16, Issue 1
- 1-3 Italian risk-sharing agreements on drugs: are they worthwhile?
by Livio Garattini & Alessandro Curto & Katelijne Vooren - 5-20 Misreporting and misclassification: implications for socioeconomic disparities in body-mass index and obesity
by Åsa Ljungvall & Ulf Gerdtham & Ulf Lindblad - 21-33 Income-related inequalities and inequities in health care services utilisation in 18 selected OECD countries
by Marion Devaux - 35-45 Demand uncertainty and hospital costs: an application to Portuguese public hospitals
by Alvaro Almeida & Joana Cima - 47-54 Do people desire to be healthier than other people? A short note on positional concerns for health
by S. Wouters & N. Exel & M. Donk & K. Rohde & W. Brouwer - 55-64 The impact of user fee removal policies on household out-of-pocket spending: evidence against the inverse equity hypothesis from a population based study in Burkina Faso
by V. Ridde & I. Agier & A. Jahn & O. Mueller & J. Tiendrebéogo & M. Yé & M. De Allegri - 65-72 Cost of poor adherence to anti-hypertensive therapy in five European countries
by F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder - 73-82 Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008
by Michael Mueller & Alexander Frenzel - 83-94 Compulsory licensing and access to drugs
by Charitini Stavropoulou & Tommaso Valletti - 95-112 Health care expenditures and longevity: is there a Eubie Blake effect?
by Friedrich Breyer & Normann Lorenz & Thomas Niebel
December 2014, Volume 15, Issue 9
- 899-906 Analysing coverage decision-making: opening Pandora’s box?
by Katharina Fischer & Reiner Leidl - 907-916 Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data
by Elisabeth Brock & Peter Braunhofer & Josef Troxler & Heinz Schneider - 917-925 Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
by Álvaro Hidalgo-Vega & Juan Ramos-Goñi & Renata Villoro - 927-936 Patient hospital choice for hip replacement: empirical evidence from the Netherlands
by Puck Beukers & Ron Kemp & Marco Varkevisser - 937-951 Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs
by Kurt Brekke & Dag Dalen & Tor Holmås - 953-966 Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)
by Uwe Zettl & Thomas Henze & Ute Essner & Peter Flachenecker - 967-977 Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD
by Clazien Bouwmans & Annemarie Kolk & Mark Oppe & Saskia Schawo & Elly Stolk & Michel Agthoven & Jan Buitelaar & LeonaHakkaart Roijen - 979-989 The impact of ageing on health care expenditures: a study of steepening
by Fredrik Gregersen - 991-998 Brand switching or reduced consumption? A study of how cigarette taxes affect tobacco consumption
by Chiang-Ming Chen & Kuo-Liang Chang & Lin Lin & Jwo-Leun Lee - 999-1010 Cost effects of hospital mergers in Portugal
by Helda Azevedo & Céu Mateus
November 2014, Volume 15, Issue 8
- 787-790 Considering productivity loss in cost-effectiveness analysis: a new approach
by Afschin Gandjour - 791-800 The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer’s disease to nursing homes: cost-effectiveness analysis in France
by Jacques Touchon & Jean Lachaine & Catherine Beauchemin & Anna Granghaud & Benoit Rive & Sébastien Bineau - 801-812 The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening
by Pauline Chauvin & Jean-Michel Josselin & Denis Heresbach - 813-828 How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011
by Astrid Kiil & Kurt Houlberg - 829-840 Methodological reviews of economic evaluations in health care: what do they target?
by Maria-Florencia Hutter & Roberto Rodríguez-Ibeas & Fernando Antonanzas - 841-851 On social polarization and ordinal variables: the case of self-assessed health
by Alessio Fusco & Jacques Silber - 853-867 The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study
by Petra Baji & Milena Pavlova & László Gulácsi & Miklós Farkas & Wim Groot - 869-883 Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
by G. Ramos & Antoinette Asselt & Sandra Kuiper & Johan Severens & Tanja Maas & Edward Dompeling & J. Knottnerus & Onno Schayck - 885-896 Population ageing and healthcare expenditure projections: new evidence from a time to death approach
by Claudia Geue & Andrew Briggs & James Lewsey & Paula Lorgelly - 897-897 Erratum to: Cost-effectiveness of febuxostat in chronic gout
by Stephen Beard & Birgitta Scheele & George Nuki & Isobel Pearson
September 2014, Volume 15, Issue 7
- 675-680 HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain
by L. Gulácsi & M. Péntek - 681-695 Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making
by Karin Cerri & Martin Knapp & Jose-Luis Fernandez - 697-708 Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland
by Maurus Rischatsch - 709-716 A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
by Douwe Postmus & Tommi Tervonen & Gert Valkenhoef & Hans Hillege & Erik Buskens - 717-735 Persistence of physical activity in middle age: a nonlinear dynamic panel approach
by Narimasa Kumagai & Seiritsu Ogura - 737-746 Choice of insurer for basic health insurance restricted by supplementary insurance
by Daniëlle Duijmelinck & Wynand Ven - 747-757 Employment effects of hospital privatization in Germany
by Mareike Heimeshoff & Jonas Schreyögg & Oliver Tiemann - 759-766 Health tourism on the rise? Evidence from the Balance of Payments Statistics
by Chung-Ping Loh - 767-772 Cost-effectiveness of lung transplantation and its evolution: the Portuguese case
by Luis Mendonça & Julian Perelman & Vanessa Rodrigues & José Fragata - 773-785 Applying discrete choice modelling in a priority setting: an investigation of public preferences for primary care models
by Chiara Seghieri & Alessandro Mengoni & Sabina Nuti
July 2014, Volume 15, Issue 6
- 563-566 Health-related development aid: what comes after it?
by Steffen Fleßa - 567-576 The effect of job loss on body weight during an economic collapse
by Sif Jónsdóttir & Tinna Ásgeirsdóttir - 577-589 Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation
by Jörg Ruof & Friedrich Schwartz & J.-Matthias Schulenburg & Charalabos-Markos Dintsios - 591-598 Does health promote economic growth? Portuguese case study: from dictatorship to full democracy
by Sónia Morgado - 599-610 Association between fee-for-service expenditures and morbidity burden in primary care
by Troels Kristensen & Kim Olsen & Henrik Schroll & Janus Thomsen & Anders Halling - 611-621 Preference for practice: a Danish study on young doctors’ choice of general practice using a discrete choice experiment
by Line Pedersen & Dorte Gyrd-Hansen - 623-643 An empirical analysis of the multimarket contact theory in pharmaceutical markets
by Javier Coronado & Sergi Jiménez-Martín & Pedro Marín - 645-652 Can health public expenditure reduce the tragic consequences of road traffic accidents? The EU-27 experience
by José Castillo-Manzano & Mercedes Castro-Nuño & Xavier Fageda - 653-660 Costs of diabetes and its complications in Poland
by Joanna Leśniowska & Agata Schubert & Michał Wojna & Iwona Skrzekowska-Baran & Marta Fedyna - 661-673 Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France
by Hassan Serrier & Hélène Sultan-Taieb & Danièle Luce & Sophie Bejean
June 2014, Volume 15, Issue 5
- 449-452 Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme
by William Green & John Hutton - 453-463 Cost-effectiveness of febuxostat in chronic gout
by Stephen Beard & Birgitta Scheele & George Nuki & Isobel Pearson - 465-475 Predicting productivity based on EQ-5D: an explorative study
by Marieke Krol & Elly Stolk & Werner Brouwer - 477-487 The effects of rebate contracts on the health care system
by Julia Graf - 489-496 Evaluating change using patient-reported outcome measures in knee replacement: the complementary nature of the EQ-5D index and VAS scores
by Fang-Ju Lin & Jennifer Samp & Alexis Munoz & Pei Wong & A. Pickard - 497-514 Explaining variations in breast cancer screening across European countries
by Ansgar Wübker - 515-531 Identifying covariates of population health using extreme bound analysis
by Fabrizio Carmignani & Sriram Shankar & Eng Tan & Kam Tang - 533-551 Testing the red herring hypothesis on an aggregated level: ageing, time-to-death and care costs for older people in Sweden
by Martin Karlsson & Florian Klohn - 553-561 Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach
by Arieh Gavious & Dan Greenberg & Ariel Hammerman & Ella Segev
May 2014, Volume 15, Issue 4
- 335-340 Orphan drugs policies: a suitable case for treatment
by Michael Drummond & Adrian Towse - 341-351 Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care: population-based Cohort study and Markov model
by Martin Gulliford & Judith Charlton & Nawaraj Bhattarai & Christopher Charlton & Caroline Rudisill - 353-362 Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
by Carole Dembek & Leigh White & Jayson Quach & Andrea Szkurhan & Nazia Rashid & M. Blasco - 363-372 Optimal choice on prevention and cure: a new economic analysis
by Mario Menegatti - 373-388 Announcement effects of health policy reforms: evidence from the abolition of Austria’s baby bonus
by Beatrice Brunner & Andreas Kuhn - 389-399 Valuing health at the end of life: an empirical study of public preferences
by Koonal Shah & Aki Tsuchiya & Allan Wailoo - 401-410 Explaining differences in remuneration rates of nursing homes in Germany
by Roman Mennicken & Boris Augurzky & Heinz Rothgang & Jürgen Wasem - 411-431 Effects of health care decentralization in Spain from a citizens’ perspective
by José-Ignacio Antón & Rafael Muñoz de Bustillo & Enrique Fernández Macías & Jesús Rivera - 433-437 Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
by Manuel Hens & Ana Villaverde-Hueso & Veronica Alonso & Ignacio Abaitua & Manuel Posada de la Paz - 439-445 Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD
by Rodrigo Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten - 447-447 Erratum to: Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD
by Rodrigo Refoios Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten
April 2014, Volume 15, Issue 3
- 223-228 Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
by María-Isabel Farfan-Portet & Sophie Gerkens & Isabelle Lepage-Nefkens & Irmgard Vinck & Frank Hulstaert - 229-242 Low birth weight and health expenditures from birth to late adolescence
by Michael Hummer & Thomas Lehner & Gerald Pruckner - 243-252 Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care: the PRaCTICaL trial
by R. Hernández & D. Jenkinson & L. Vale & B. Cuthbertson - 253-263 Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity
by Bruce Wang & Edwin Wong & Rafael Alfonso-Cristancho & Hao He & David Flum & David Arterburn & Louis Garrison & Sean Sullivan - 265-279 Education, cognition, health knowledge, and health behavior
by Naci Mocan & Duha Altindag - 281-288 Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best–worst scaling?
by Feng Xie & Eleanor Pullenayegum & Kathryn Gaebel & Mark Oppe & Paul Krabbe - 289-302 The effect of quality and socio-demographic variables on efficiency measures in primary health care
by José Cordero Ferrera & Eva Cebada & Luis Murillo Zamorano - 303-311 Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partners
by Poul Jennum & Rikke Ibsen & Kirsten Avlund & Jakob Kjellberg - 313-321 Blood donation as a public good: an empirical investigation of the free rider problem
by Ignacio Abásolo & Aki Tsuchiya - 323-334 Equity in specialist waiting times by socioeconomic groups: evidence from Spain
by Ignacio Abásolo & Miguel Negrín-Hernández & Jaime Pinilla
March 2014, Volume 15, Issue 2
- 113-116 Is the US “leading from behind” on health policy?
by Peter Neumann & Cayla Saret - 117-132 Is there room for containing healthcare costs? An analysis of regional spending differentials in Italy
by Maura Francese & Marzia Romanelli - 133-142 Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data
by Simon Frey & Roland Linder & Georg Juckel & Tom Stargardt - 143-156 Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism
by Moshe Levy & Adi Rizansky - 157-174 Economic evaluations of homeopathy: a review
by Petter Viksveen & Zofia Dymitr & Steven Simoens - 175-186 Hospital efficiency under prospective reimbursement schemes: an empirical assessment for the case of Germany
by Helmut Herwartz & Christoph Strumann - 187-201 The impact of health worker migration on development dynamics: evidence of wealth effects from Africa
by Simplice Asongu - 203-221 Socioeconomic inequalities in adult obesity risk in Canada: trends and decomposition analyses
by Mohammad Hajizadeh & M. Karen Campbell & Sisira Sarma
January 2014, Volume 15, Issue 1
- 1-5 The organ crisis: a disaster of our own making
by T. Randolph Beard & Rigmar Osterkamp - 7-18 Health state utilities for skeletal-related events secondary to bone metastases
by Louis Matza & Karen Chung & Kate Brunt & John Brazier & Ada Braun & Brooke Currie & Andrew Palsgrove & Evan Davies & Jean-Jacques Body - 19-39 The impact of tobacco prices on smoking onset in Vietnam: duration analyses of retrospective data
by G. Guindon - 41-55 Willingness-to-accept reductions in HIV risks: conditional economic incentives in Mexico
by Omar Galárraga & Sandra Sosa-Rubí & César Infante & Paul Gertler & Stefano Bertozzi - 57-68 The effect of health on labour supply in nine former Soviet Union countries
by Yevgeniy Goryakin & Lorenzo Rocco & Marc Suhrcke & Bayard Roberts & Martin McKee - 69-82 Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
by Yevgeniy Samyshkin & Robert Kotchie & Ann-Christin Mörk & Andrew Briggs & Eric Bateman - 83-91 Changes in the remuneration system for general practitioners: effects on contact type and consultation length
by Christel Dijk & Robert Verheij & Hans te Brake & Peter Spreeuwenberg & Peter Groenewegen & Dinny Bakker - 93-112 Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique
by Bonny Parkinson & Sallie-Anne Pearson & Rosalie Viney
May 2014, Volume 15, Issue 1
- 1-4 Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries
by László Gulácsi - 5-11 Statistical and regulatory considerations in assessments of interchangeability of biological drug products
by Lászlo Tóthfalusi & László Endrényi & Shein-Chung Chow - 13-25 Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
by László Gulácsi & Alexandru Rotar & Maciej Niewada & Olga Löblová & Fanni Rencz & Guenka Petrova & Imre Boncz & Niek Klazinga - 27-34 Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
by László Gulácsi & Fanni Rencz & Márta Péntek & Valentin Brodszky & Ruth Lopert & Noémi Hevér & Petra Baji - 35-43 Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
by Márta Péntek & Gyula Poór & Piotr Wiland & Martina Olejárová & Marek Brzosko & Catalin Codreanu & Nóra Brodszky & László Gulácsi - 45-52 Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
by Petra Baji & Márta Péntek & Sándor Szántó & Pál Géher & László Gulácsi & Orsolya Balogh & Valentin Brodszky - 53-64 Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
by Petra Baji & Márta Péntek & László Czirják & Zoltán Szekanecz & György Nagy & László Gulácsi & Valentin Brodszky - 65-71 Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
by Valentin Brodszky & Petra Baji & Orsolya Balogh & Márta Péntek - 73-82 Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
by Márta Péntek & Bernadette Rojkovich & László Czirják & Pál Géher & Péter Keszthelyi & Attila Kovács & László Kovács & Zita Szabó & Zoltán Szekanecz & László Tamási & Ágnes Tóth & Ilona Ujfalussy & Noémi Hevér & Bálint Strbák & Petra Baji & Valentin Brodszky & László Gulácsi - 83-92 Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
by Márta Péntek & László Gulácsi & Bernadette Rojkovich & Valentin Brodszky & Job Exel & Werner Brouwer - 93-100 Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis
by Katalin Gulyas & Nora Bodnar & Zsofia Nagy & Szilvia Szamosi & Agnes Horvath & Andrea Vancsa & Edit Vegh & Zoltan Szabo & Gabriella Szucs & Zoltan Szekanecz & Sandor Szanto - 101-109 Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
by Orsolya Balogh & Valentin Brodszky & László Gulácsi & Emese Herédi & Krisztina Herszényi & Hajnalka Jókai & Sarolta Kárpáti & Petra Baji & Éva Remenyik & Andrea Szegedi & Péter Holló - 111-119 Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
by Emese Herédi & Fanni Rencz & Orsolya Balogh & László Gulácsi & Krisztina Herszényi & Péter Holló & Hajnalka Jókai & Sarolta Kárpáti & Márta Péntek & Éva Remenyik & Andrea Szegedi & Valentin Brodszky - 121-128 Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
by Mandel Michael & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos - 129-129 Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
by Michael Mandel & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos - 131-135 Economic burden of long-term care of rheumatoid arthritis patients in Hungary
by Zoltán Horváth & Andor Sebestyén & August Österle & Dóra Endrei & József Betlehem & András Oláh & László Imre & Gabriella Bagosi & Imre Boncz - 137-141 Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010
by Imre Boncz & Réka Vajda & István Ágoston & Dóra Endrei & Andor Sebestyén
December 2013, Volume 14, Issue 6
- 847-852 Channeling health economics research initiatives to improve decision-making processes in the EU
by F. Antonanzas & R. Rodríguez-Ibeas - 853-861 Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease
by Monia Marchetti & Nicola Liberato & Antonio Sabatino & Gino Corazza - 863-873 The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
by Ingrid Lekander & Fredrik Borgström & Jörgen Lysholm & Ronald Vollenhoven & Staffan Lindblad & Pierre Geborek & Gisela Kobelt - 875-885 Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
by P. Laires & F. Exposto & R. Mesquita & A. Martins & L. Cunha-Miranda & J. Fonseca - 887-899 The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies
by Jen Kruger & Alan Brennan - 901-909 Internal validation of models with several interventions
by Afschin Gandjour & Amiram Gafni - 911-918 Quantifying short run cost-effectiveness during a gradual implementation process
by Gijs Wetering & Willem Woertman & Andre Verbeek & Mireille Broeders & Eddy Adang - 919-927 Explaining length of stay variation of episodes of care in the Netherlands
by Siok Tan & Leona Hakkaart-van Roijen & B. Ineveld & W. Redekop - 929-938 Managing for efficiency in health care: the case of Greek public hospitals
by Panagiotis Mitropoulos & Ioannis Mitropoulos & Aris Sissouras - 939-945 Treatment costs of attention deficit hyperactivity disorder in Germany
by Sebastian Braun & Jan Zeidler & Roland Linder & Susanne Engel & Frank Verheyen & Wolfgang Greiner - 947-957 Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information
by Leyla Mohseninejad & Talitha Feenstra & Henriëtte Horst & Hèlen Woutersen-Koch & Erik Buskens - 959-969 The impact of generic reference pricing in Italy, a decade on
by Simone Ghislandi & Patrizio Armeni & Claudio Jommi - 971-977 Maximal endurable time states and the standard gamble: more preference reversals
by P. Stalmeier & A. Verheijen - 979-994 How efficient are Greek hospitals? A case study using a double bootstrap DEA approach
by Kostas Kounetas & Fotis Papathanassopoulos - 995-1002 Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children
by Peter Kiencke & Kristina Viehmann & Reinhard Rychlik - 1003-1013 Long-term health investment when people underestimate their adaptation to old age-related health problems
by Octave Jokung & Serge Macé - 1015-1026 Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
by Bernhard Ultsch & Ingrid Köster & Thomas Reinhold & Anette Siedler & Gérard Krause & Andrea Icks & Ingrid Schubert & Ole Wichmann - 1027-1034 TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial
by G. Koning & E. Adang & P. Stalmeier & F. Keus & P. Vriens & C. Laarhoven - 1035-1048 Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation
by Björn Stollenwerk & Afschin Gandjour & Markus Lüngen & Uwe Siebert
October 2013, Volume 14, Issue 5
- 709-713 Could co-payments on drugs help to make EU health care systems less open to political influence?
by Livio Garattini & Katelijne Vooren - 715-723 Analysis of HIV/AIDS DRG in Portugal: a hierarchical finite mixture model
by Sara Dias & Valeska Andreozzi & Rosário Martins - 725-737 Soft budget constraints in health care: evidence from Italy
by Rosella Levaggi & Francesco Menoncin - 739-748 Public preferences for establishing nephrology facilities in Greenland: estimating willingness-to-pay using a discrete choice experiment
by Trine Kjær & Mickael Bech & Christian Kronborg & Morten Mørkbak - 749-759 Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia
by Keith Tolley & Catherine Goad & Yunni Yi & Penny Maroudas & Amin Haiderali & Gwilym Thompson - 761-773 Examining the determinants of drug launch delay in pre-TRIPS India
by Saradindu Bhaduri & Thomas Brenner - 775-787 Evaluating the redistributive impact of public health expenditure using an insurance value approach
by Amedeo Spadaro & Lucia Mangiavacchi & Ignacio Moral-Arce & Marta Adiego-Estella & Angela Blanco-Moreno - 789-797 The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
by Carla Guerriero & John Cairns & Ian Roberts & Anthony Rodgers & Robyn Whittaker & Caroline Free - 799-808 Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study
by Sarah Mostardt & Nikola Hanhoff & Jürgen Wasem & Armin Goetzenich & Knud Schewe & Eva Wolf & Christoph Mayr & Hans Jaeger & Holger Pfaff & Stephan Dupke & Anja Neumann - 809-820 Hospital readmission among elderly patients
by Afsaneh Bjorvatn - 821-834 What determines health: a causal analysis using county level data
by Andrew Rettenmaier & Zijun Wang - 835-846 Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries
by Christian Eckmann & Matthew Wasserman & Faisal Latif & Graeme Roberts & Axelle Beriot-Mathiot
August 2013, Volume 14, Issue 4
- 569-571 The present state of health economics: a critique and an agenda for the future
by Peter Zweifel - 573-586 Welfare standards in hospital mergers
by Katalin Katona & Marcel Canoy - 587-599 Assessing the impact of national antibiotic campaigns in Europe
by M. Filippini & L. Ortiz & G. Masiero - 601-613 What do physicians dislike about managed care? Evidence from a choice experiment
by Maurus Rischatsch & Peter Zweifel